Found 12 matching trials
Convalescent Plasma to Limit SARS-CoV-2 Associated Complications
PHASE2To assess the efficacy and safety of Human coronavirus immune plasma (HCIP)...
Location
University of Alabama at Birmingham
Evaluation of Safety, Tolerability and Immune Responses of Ebola-S and Marburg Vaccines in Healthy Adults
PHASE1Primary Objective:
• To evaluate the safety and tolerability of cAd3-EBO-S...
Location
Oklahoma Blood Institute (OBI)
Adaptive Immune Response to COVID-19 Vaccination
N/AAICOVI (Adaptive Immune Response to COVID-19 Vaccination) is a prospective ...
Location
University Medicine Greifswald
Differences in Immune Response Among HIV-1-infected Individuals With Previous or Current COVID-19 (CoVIHDis).
N/APeople living with HIV could have different susceptibility and outcome to t...
Location
Hospital Ramon y Cajal
Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia
PHASE3REMAP-CAP is a randomised, embedded, multifactorial, adaptive platform tria...
Location
University of Florida
Neurobiological Underpinnings of Neuropsychological Consequences in Long COVID
N/AObjectives:
To describe the standardized evaluation of the psychological a...
plasmApuane CoV-2 : Efficacy and Safety of Immune Covid-19 Plasma in Covid-19 Pneumonia in Non ITU Patients
PHASE2Aim of the study is to verify the efficacy and safety of convalescent hyper...
Location
Ospedale delle Apuane
Efficacy of the Infusion of Donor Plasma in COVID-19 Infection
PHASE3Objectives Primary objectives To assess the superiority or not of the infus...
Location
Hospital Galdakao-Usansolo
Convalescent Plasma to Stem Coronavirus (CSSC-001)
PHASE2Evaluate the efficacy of treatment with high-titer Anti- SARS-CoV-2 plasma ...
Location
University of Alabama at Birmingham
Study of the Kinetics of COVID-19 Antibodies for 24 Months in Patients With Confirmed SARS-CoV-2 Infection
NAThe main objective of the study is to describe the temporal curve of COVID-...